Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer

Robert Siegel, MD
Published: Tuesday, Aug 22, 2017



Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.

Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.
 
SELECTED
LANGUAGE


Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

In a phase II study, the efficacy of induction chemotherapy and transoral surgery was studied as a definitive treatment for oropharyngeal squamous cell carcinoma.

Through this regimen, Siegel hopes to eliminate the morbidly of radiation therapy, which is the current standard of care for these patients.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication
x